Clinical Trial

A Study on the Safety and Preliminary Efficacy of NK042 in the Treatment of Malignant Ascites

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2024 (before its estimated December 6, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess the safety and efficacy of NK042 for treatment of malignant ascites.
Trial Details
NCT Number NCT06415500
Lead Sponsor Anhui Provincial Hospital
Conditions Gynecologic Cancer
Enrollment 9 participants
Start Date 2024-05-06
Primary Completion 2025-12-06 (estimated)
Study Completion 2026-12-06 (estimated)
Updated on ClinicalTrials.gov 2024-05-16